現代牙科(03600.HK):訂單今年續見增長 牙科數碼化助毛利改善
現代牙科(03600.HK)首席財務官關毅傑在記者會表示,疫情下,把握機會向牙醫作推廣,令去年下半年業績增長至歷史新高。主席兼執行董事陳奕朗指,今年牙科圈情況更比去年下半年好,牙醫亦見更多預約,利好公司訂單。
關毅傑指,公司將加緊投資數碼化,如由牙模改用掃描機,可以節省運輸,公司亦有售口腔掃描機,目前亦正考慮設計假牙數碼化解決方案。
他指,樂見更多牙醫願意利用數碼化,去年來自數碼化的訂單多20%,當中現有客戶訂單量增長10%。同時數碼化有助降低營運成本,並改善毛利,去年毛利率增2個百分點至52%,相信隨著滲透率增加,會進一步改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.